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A B S T R A C T
Background: Recent studies report deficits in social cognition in individuals with multiple sclerosis (MS). Social
cognitive skills such as empathy are important for adequate social and occupational functioning. Our objectives
are: (1) to examine whether empathy differs between individuals with MS and healthy controls, (2) to examine
relations between empathy and cognitive, psychological and occupational functioning.
Methods: 278 individuals with MS (relapsing-remitting subtype) and 128 healthy controls from the MS@Work
study participated in this investigation. The participants completed questionnaires about demographics, cog-
nitive, psychological and occupational functioning, and underwent neurological and neuropsychological ex-
aminations. Mann-Whitney U-tests were used to examine group differences in empathy. Pearson and Spearman
rank correlation analyses were used to examine relations between empathy and the other measures.
Results: Empathy did not differ between individuals with MS and healthy controls. In individuals with MS,
higher empathy was correlated with a higher educational level (X2(df) = 13.2(2), p = 0.001), better verbal
learning (r = 0.20, p = 0.001), less symptoms of depression (r=−0.21, p = 0.001), higher extraversion
(r = 0.25, p ≤ 0.001), agreeableness (r = 0.55, p ≤ 0.001) and conscientiousness (r = 0.27, p ≤ 0.001) and
better occupational functioning in terms of work scheduling and output demands (r = 0.23, p = 0.002) and less
cognitive/psychological work barriers (r = −0.21, p = 0.001). In healthy controls, higher empathy was cor-
related with less symptoms of depression (r = −0.34, p ≤ 0.001), less fatigue (r = −0.37, p ≤ 0.001), higher
agreeableness (r = 0.59, p≤ 0.001) and better occupational functioning in terms of work ability as compared to
lifetime best (r = 0.28, p = 0.001) and less cognitive/psychological work barriers (r = −0.34, p ≤ 0.001).
Empathy did not differ between unemployed and employed individuals with MS or healthy controls.
Conclusion: Empathy did not differ between individuals with MS and healthy controls. Within both investigated
groups, higher empathy was weakly to moderately correlated with less symptoms of depression, higher agree-
ableness and better occupational functioning. We also found unique correlations for empathy within the
https://doi.org/10.1016/j.msard.2020.102036
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investigated groups. Longitudinal studies are needed to further examine social cognition in relation to cognitive,
psychological and occupational functioning in both individuals with MS and healthy controls. It would be
particularly interesting to concurrently examine changes in the brain network involved with social cognition.
1. Introduction
Many studies have reported the high prevalence (40% to 65%) and
impact of cognitive impairment across all stages and clinical courses of
multiple sclerosis (MS) (Amato et al., 2006). These studies found evi-
dence for impairments in -among others- information processing speed,
memory and executive functioning. In the past decade more attention is
being devoted to examining social cognition and how deficits in this
area impact individuals with MS.
The term social cognition refers to mental functions that underlie
social interactions. It involves constructs such as social perception (the
ability to perceive information about the mental state of others based
on behavioural signals), empathy (the ability to understand the inten-
tions of others, predict their behaviour and experience an emotion
triggered by their emotion) and theory of mind (ToM; the ability to
attribute mental states to oneself or others) (Green et al., 2008;
Labbe et al., 2018; Baron-Cohen and Wheelwright, 2004). Such func-
tional abilities are vital for developing deep social interactions and may
impact employment as well as relationships with friends, family and
caregivers. Social cognition relies on a broad network of brain regions
involving subcortical and neocortical brain areas, including the medial
prefrontal cortex (Labbe et al., 2018; Decety, 2011).
Recent studies provide evidence for reduced empathy and ToM in
individuals with MS, even in the early stages of relapsing-remitting MS
(Gleichgerrcht et al., 2015; Almeida et al., 2016; Kraemer et al., 2013;
Banati et al., 2010; Pottgen et al., 2013). Individuals with MS were
specifically impaired in the recognition of negative facial emotional
expressions and the ability to infer mental states of others during visual
tasks (i.e. images and videos) (Cotter et al., 2016). Impairments in so-
cial cognition in MS were generally not found to be related to disease
duration, degree of disability, relapse rate or disease course
(Gleichgerrcht et al., 2015; Almeida et al., 2016; Kraemer et al., 2013;
Dulau et al., 2017). Positive associations have been demonstrated be-
tween social cognition and the traditionally investigated cognitive
functions (i.e. memory, information processing speed and executive
functioning) (Kraemer et al., 2013; Pottgen et al., 2013; Dulau et al.,
2017; Chalah et al., 2017). However, reduced social cognition in MS
does appear to be independent of general cognitive impairment,
meaning that reduced social cognition is not simply a consequence of
cognitive impairment (Pottgen et al., 2013). Further research is needed
to clarify the association between social cognition on the one hand and
MS disease characteristics and cognitive performance on the other hand
(Cotter et al., 2016).
Given that social cognitive skills such as empathy are perceived vital
for occupational success (Longmire and Harrison, 2018; van der Klink
et al., 2016) and considering that work participation is often compro-
mised in MS (Julian et al., 2008), it is of special interest to examine
relations between social cognition and occupational functioning in MS.
To the best of our knowledge, the relationship between social cognition
and occupational functioning in MS has not been previously in-
vestigated.
In the current study we will specifically focus on empathy, affective
ToM and emotional reactivity as measured with Baron-Cohen's
Empathy Quotient (Baron-Cohen and Wheelwright, 2004). Our objec-
tives are (1) to examine whether empathy differs between individuals
with MS and controls, (2) to examine relations between empathy and
cognitive, psychological and occupational functioning. Based on pre-
vious studies, we expect to find reduced empathy in individuals with
MS as compared with healthy controls (Gleichgerrcht et al., 2015;
Almeida et al., 2016; Kraemer et al., 2013; Banati et al., 2010;
Pottgen et al., 2013). Furthermore, we expect to find correlations be-
tween higher empathy and better executive functioning (Kraemer et al.,
2013; Dulau et al., 2017), information processing speed (Pottgen et al.,
2013; Dulau et al., 2017; Chalah et al., 2017) and learning and delayed
memory (Pottgen et al., 2013; Dulau et al., 2017), and between higher
empathy and better occupational functioning. In accordance with pre-
vious studies, we do not expect to find correlations between empathy
and disease duration, disability and symptoms of depression
(Gleichgerrcht et al., 2015; Almeida et al., 2016; Kraemer et al., 2013;
Chalah et al., 2017). These correlations may not be unique to in-
dividuals with MS, and we therefore expect similar correlations be-
tween empathy and cognitive, psychological and occupational func-
tioning in healthy controls.
2. Material and methods
2.1. Design and participants
278 individuals with MS (relapsing-remitting subtype) who had
participated in the MS@Work study, a prospective longitudinal study
on work participation in individuals with relapsing-remitting MS, were
included in this investigation (van der Hiele et al., 2015). The in-
dividuals with MS were recruited from 16 MS outpatient clinics in the
Netherlands. The criteria for inclusion were a diagnosis of relapsing-
remitting MS according to the Polman-McDonald criteria 2010
(Polman et al., 2011), at least 18 years old and having a paid job or
within three years since the last past job. Individuals with co-morbid
psychiatric and neurological disorders, substance abuse, neurological
impairment that might interfere with cognitive testing, unable to speak
and/or read Dutch, or who did not complete Baron-Cohen's Empathy
Quotient were excluded from the study.
We recruited 128 healthy controls via advertisements on social
media and in local newspapers. The criteria for inclusion were 18 years
or older and having a paid job or within three years since the last paid
job. Individuals with a psychiatric, neurological or other chronic dis-
order, substance abuse, or unable to speak and/or read Dutch were
excluded.
The study was approved by the Medical Ethical Committee Brabant
(NL43098.008.12 1307) and the Board of Directors of the participating
MS outpatient clinics. All participating subjects provided written in-
formed consent. The study is performed in agreement with the de-
claration of Helsinki (World Medical, 2013). Reporting of this study
was performed according to the STROBE guidelines (von Elm et al.,
2007).
2.2. Procedure
Individuals with MS underwent yearly neurological and neu-
ropsychological examinations at their MS outpatient clinic for a period
of three years. The healthy controls underwent a neuropsychological
examination at baseline. All participants were asked to complete yearly
online questionnaires on demographic characteristics, occupational
functioning, empathy, self-reported cognitive and neuropsychiatric
functioning, fatigue and mood for a period of three years. The current
study focuses on the baseline phase, which took place between March
2014 and January 2017. For more details about the MS@Work study
we refer to the study protocol (van der Hiele et al., 2015)




Baron-Cohen's Empathy Quotient (Baron-Cohen and
Wheelwright, 2004; Lawrence et al., 2004), a self-report questionnaire,
was used to assess empathy, affective ToM and emotional reactivity.
Higher scores indicate more empathy; low empathy: 0–32; average
empathy: 33–52, above average: 53–63; very high empathy: 64–80
(Baron-Cohen, 2012).
2.3.2. Neurological examination
The neurological examination included the Expanded Disability
Status Scale (EDSS) (Kurtzke, 1983). Higher scores indicate more
symptoms and disability due to MS. The EDSS was administered by a
neurologist.
2.3.3. Cognitive examination
We used the Paced Auditory Serial Addition Test (3 s version)
(PASAT) (Gronwall, 1977) (total correct) and the written version of the
Symbol Digit Modalities Test (SDMT) (Smith, 1982) (total correct) to
examine information processing speed and working memory. Higher
scores on the PASAT and SDMT indicate higher information processing
speed and better working memory. The Rey Verbal Learning Test
(RVLT) (Brand, 1985) (total correct learning trials 1–5 and total correct
delayed recall) and Brief Visuospatial Memory Test-Revised (BVMT-R)
(Benedict et al., 1996) (total correct learning trials 1–3 and total correct
delayed recall) were used to examine learning and memory capacities.
Higher scores indicate better learning and memory. The Trail Making
Test (TMT) (Reitan, 1956) and the Design Fluency (DF) and Colour
Word Interference (CWI) subtests of the Delis-Kaplan Executive Func-
tion System (Delis et al., 2004) were used to examine executive func-
tioning. Lower TMT (TMT B-A index) and CWI contrast scores (timecard
3 + 4 minus card 1 + 2) and higher DF scores (total correct) indicate
better executive functioning.
2.3.4. Neuropsychiatric examination
The Hospital Anxiety and Depression Scale (HADS) (Zigmond and
Snaith, 1983) was used to assess symptoms of anxiety and depression.
Higher subscale scores indicate more symptoms of anxiety or depres-
sion. The Modified Fatigue Impact Scale-20 (MFIS) (Kos et al., 2003)
was used to determine the physical, psychosocial and cognitive impact
of fatigue. Higher scores indicate a higher impact of fatigue on daily
functioning. The NEO Five-Factor Personality Inventory (NEO-FFI)
(Hoekstra et al., 1996) was used to assess the extent to which the
personality traits of neuroticism, extraversion, openness, agreeableness
and conscientiousness are present. Higher scores indicate a higher
presence of the respective personality traits.
2.3.5. Occupational functioning
Work status was dichotomized as ‘paid job’ or ‘no paid job’ (irre-
spective of the number of working hours). A single item of the Work
Productivity and Activity Impairment Questionnaire (Reilly et al.,
1993) ‘presenteeism’ was used to examine the self-reported influence of
MS symptoms on productivity while at work in the past 7 days. Higher
scores were considered to indicate a higher negative influence of MS
symptoms on work productivity. The Work Role Functioning Ques-
tionnaire-2.0 (WRFQ-2.0) (Abma et al., 2012; Abma et al., 2016) was
used to examine work role functioning, i.e. the perceived percentage of
time that physical and emotional problems impact certain work de-
mands. There are four subscales, i.e. work scheduling and output de-
mands, physical demands, mental and social demands, and flexibility
demands, with higher scores indicating better work role functioning. A
single item of the Work Ability Index (WAI) (Ahlstrom et al., 2010) was
used to examine current work ability as compared to lifetime best.
Higher scores indicate better work ability as compared to lifetime best.
The shortened version of the Multiple Sclerosis Work Difficulties
Questionnaire (MSWDQ-23) (Honan et al., 2014) was used to examine
psychological/cognitive, physical and external work difficulties. Higher
scores indicate greater work difficulties.
2.4. Statistical analyses
Mann-Whitney U tests and Χ2 tests were used to examine differences
in demographics, disease characteristics and empathy between in-
dividuals with MS and healthy controls.
Spearman rank and Pearson correlation analyses (depending on the
data distribution) were performed to examine correlations between
empathy and demographic, neurological, cognitive, and neu-
ropsychiatric characteristics in individuals with MS and healthy con-
trols.
To examine relations between empathy and occupational func-
tioning, we first used a Mann-Whitney U test to examine differences in
empathy between participants with and without a paid job. Spearman
rank correlation analyses were then performed to examine correlations
between empathy and presenteeism, work ability, work role func-
tioning and work difficulties in individuals with MS and healthy con-
trols.
As additional explorative analyses, Mann-Whitney U tests and in-
dependent t-tests were used to examine differences in cognitive, neu-
ropsychiatric and occupational characteristics between individuals with
MS and healthy controls.
p-values ≤ 0.05 were considered statistically significant. To correct
for multiple testing, a Bonferroni correction was applied for the mul-
tiple correlation analyses within the MS and healthy control subgroups
where p-values ≤ 0.002 were considered statistically significant. SPSS
for Windows (release 23.0) was used for data analysis.
3. Results
3.1. Sample characteristics
Healthy controls were younger (U = 15,072.5, p = 0.03) and were
more highly educated (Χ2(df) = 48.0(2), p < 0.001) than individuals
with MS. The individuals with MS mostly had a low disability level (see
Table 1).
3.2. Empathy in individuals with MS as compared with healthy controls
Mann–Whitney U-tests showed that individuals with MS
(Median = 46.0) and healthy controls (Median = 49.0) did not differ
in empathy scores (U = 15,671.50, p = 0.053). Within the individuals
with MS, 9% reported low, 66% average, 21% above average and 4%
very high levels of empathy. Within the healthy controls, 9% reported
low, 58% average, 27% above average and 6% very high levels of
empathy
As educational level and age were higher in healthy controls
Table 1
Demographic and disease characteristics of the individuals with MS and healthy
controls (HC).
MS (N = 278) HC (N = 128)
Gender (female), N (%) 216 (78%) 94 (73%)
Age (years), median (IQR) 43.0 (14.0) 39.0 (18.0)
Educational level
High, N (%) 113 (41%) 98 (77%)
Medium, N (%) 118 (42%) 27 (21%)
Low, N (%) 47 (17%) 3 (2%)
EDSS, median (IQR) 2.0 (1.5) –
Disease duration (years), median (IQR) 5.0 (8.0) –
IQR: Interquartile Range. Medians (IQR) were noted as the variables had a non-
parametric distribution. EDSS: Expanded Disability Status Scale.
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(Table 1), we examined whether empathy differed between individuals
with MS and healthy controls within low, medium and high educational
groups and within low and high age groups (based on a median split).
No differences in empathy between individuals with MS and healthy
controls were found within either subgroup.
3.3. Relations between empathy and demographic, neurological, cognitive,
and neuropsychiatric characteristics of the individuals with MS and healthy
controls
Kruskal–Wallis and post-hoc Mann–Whitney tests showed that em-
pathy scores were lower for individuals with MS with a low educational
level (Median = 41.0) versus individuals with MS with either a
medium (Median = 46.0) or high educational level (Median = 47.0)
(X2(df) = 13.2(2), p = 0.001). Within individuals with MS, we found
significant correlations between higher empathy scores and better
verbal learning, less symptoms of depression, higher extraversion,
agreeableness and conscientiousness (Table 2).
A Kruskal-Wallis test showed no differences in empathy for healthy
controls with a low (Median=51.0), medium (Median = 50.0) or high
educational level (Median = 49.0) (X2(df) = 0.09 (2), p = 0.96).
Within healthy controls, we found significant correlations between
higher empathy scores and less symptoms of depression, less fatigue
and higher agreeableness (Table 2).
3.4. Relations between empathy and occupational functioning in individuals
with MS and healthy controls
Mann–Whitney U-tests showed that empathy did not differ between
employed (Median = 46.0) and unemployed individuals with MS
(Median = 45.5) (U= 4007.50, p= 0.23). It should be noted that most
individuals with MS (86.3%) were employed. Within the individuals
with MS, we found significant correlations between higher empathy
scores and better occupational functioning in terms of work scheduling
and output demands and less cognitive/psychological work barriers
(Table 3).
Mann–Whitney U-tests showed that empathy did not differ between
employed (Median = 49.0) and unemployed healthy controls
(Median = 35.5) (U = 63.5, p = 0.26). Most healthy controls (98.4%)
were employed. Within the healthy controls, we found significant cor-
relations between higher empathy scores and better occupational
functioning in terms of work ability as compared to lifetime best and
less cognitive/psychological work barriers (Table 3).
3.5. Additional explorative analyses: differences in cognitive,
neuropsychiatric and occupational functioning between individuals with MS
and healthy controls
The cognitive, neuropsychiatric and occupational characteristics of
the individuals with MS and healthy controls are reported in Table 4.
In terms of cognitive functioning, individuals with MS scored worse
on the PASAT 3.0 (U = 12,798.5, p < 0.001), SDMT (U = 10,393.5,
p < 0.001), RVLT learning (U = 11,802.0, p < 0.001), RVLT delayed
recall (U = 13,306.0, p = 0.001), BVMT-R learning (U = 14,024.5,
p = 0.03), BVMT-R delayed recall (U = 13,604.5, p = 0.007) and TMT
trails B-A (U = 14,541.5, p = 0.04) than healthy controls.
In terms of neuropsychiatric functioning, individuals with MS re-
ported more symptoms of depression (U = 8132.0, p < 0.001) and
anxiety (U = 11,900.0, p < 0.001), were more fatigued (t
(df) = −11,9(300), p < 0.001) and scored higher on the personality
trait neuroticism (U = 13,917.0, p < 0.001) and lower on the per-
sonality traits extraversion (U = 12,053.0, p < 0.001) openness
(U = 12,200.0, p < 0.001) and conscientiousness (U = 14,258.5,
p = 0.002) than healthy controls.
In terms of occupational functioning, individuals with MS reported
more presenteeism (U = 7882.0, p < 0.001), decreased work
functioning in terms of physical demands (U = 4582.00, p = 0.05),
decreased work ability as compared to lifetime best (U = 6400.5,
p < 0.001), and more physical (U = 6887.0, p < 0.001), cognitive/
psychological (U = 11,723.0, p < 0.001) and external work barriers
(U = 10,017.0, p < 0.001) than healthy controls.
4. Discussion
Recent studies reported decreased social cognitive skills in in-
dividuals with MS (Gleichgerrcht et al., 2015; Almeida et al., 2016;
Kraemer et al., 2013; Banati et al., 2010; Pottgen et al., 2013;
Cotter et al., 2016) which may have important implications for their
social and occupational functioning. The current study examined dif-
ferences in empathy between individuals with MS and healthy controls.
We further examined correlations between empathy and cognitive,
psychological and occupational functioning in both individuals with MS
and healthy controls.
4.1. 3.6. Empathy in individuals with MS as compared with healthy controls
Our study revealed no differences in empathy between individuals
with MS and healthy controls, as assessed with Baron-Cohen's Empathy
Quotient. This is in contrast with previous research in relapsing-re-
mitting MS, which showed lower empathy in individuals with (early
stage) relapsing-remitting MS as compared with healthy controls
(Almeida et al., 2016; Kraemer et al., 2013). Our finding is also in
contrast with the study by Banati et al. who found that individuals with
MS with less than 7 years of disease duration reported higher empathy
than healthy controls (Banati et al., 2010). They suggested that em-
pathy might either be overrated due to impaired ToM performance in
their sample (and associated brain damage), or that empathy might be
higher in the early disease stages due to a more focused emotional
processing. This finding could however not be replicated in the current
study when examining a subgroup of recently diagnosed individuals
Table 2
Correlations between empathy and demographic, neurological, cognitive, and





Disease duration in years −0.05 n.a.
PASAT 3.0 s version 0.0 0.06
SDMT correct 0.14 0.03
RVLT learning 0.20* 0.11
RVLT delayed recall 0.14 0.13
BVMT-R learning 0.02 0.05
BVMT-R delayed recall 0.04 −0.03
TMT trails B-A −0.04 0.02
DF total correct 0.09 −0.08
CWI card 3 + 4 minus card 1 + 2 −0.09 −0.11
HADS depression −0.21* −0.34*
HADS anxiety −0.18 −0.22
MFIS −0.06 −0.37*
NEO-FFI neuroticism −0.17 −0.12
NEO-FFI extraversion 0.25* 0.23
NEO-FFI openness 0.17 0.16
NEO-FFI agreeableness 0.55* 0.59*
NEO-FFI conscientiousness 0.27* 0.24
Pearson's or Spearman's correlation coefficients are noted. EDSS: Expanded
Disability Status Scale, PASAT: Paced Auditory Serial Addition Test, SDMT:
Symbol Digit Modalities Test, RVLT: Rey Verbal Learning Test, BVMT-R: Brief
Visuospatial Memory Test-Revised, TMT: Trail Making Test, DF: Design Fluency
Test, CWI: Colour Word Interference Test, HADS: Hospital Anxiety and
Depression Scale, MFIS: Modified Fatigue Impact Scale, NEO-FFI: NEO Five-
Factor Personality Inventory.
⁎ p ≤ 0.002, n.a.: not applicable.
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with MS (data not reported). In fact, empathy was not related to disease
duration in our study sample. The median Empathy Quotient for in-
dividuals with MS in the current study (46.0) was higher than the
median Empathy Quotients of respectively 37.4 and 40.0 reported in
the studies by Kraemer et al. (2013) (German population) and
Chalah et al. (2017) (French population), and lower than the Empathy
Quotient found in the study by Banati et al. (2010) (Hungarian popu-
lation), which was above 56.0. These differing empathy scores
measured using the same instrument may indicate possible cultural
differences in self-ratings of empathy. Another explanation for our
contrasting findings may be that the sample sizes in the aforementioned
studies were relatively small (Almeida et al., 2016; Kraemer et al.,
2013; Banati et al., 2010).
The conflicting results on whether empathy is different in in-
dividuals with MS as compared with healthy controls indicate the need
for further study. As noted by Kraemer et al. (2013) it would be of great
interest to examine intra-individual changes in empathy and ToM
during the course of MS in a larger sample.
4.2. 3 7. Relations between empathy and demographics, cognitive and
psychological functioning
In the current study we found that higher empathy was weakly to
moderately correlated with a higher educational level, better verbal
learning, less symptoms of depression, and higher extraversion, agree-
ableness and conscientiousness in individuals with MS. In healthy
controls, higher empathy was weakly to moderately correlated with less
symptoms of depression, less fatigue and higher agreeableness.
The relationship between social cognition and educational level in
individuals with MS has been reported in some studies (Chalah et al.,
2017; Prochnow et al., 2011), but not in others (Batista et al., 2017;
Batista et al., 2017) depending on the age, disability and MS subtype
distribution of the sample involved. To be more specific, the
Table 3
Correlations between empathy and occupational functioning in individuals with




Work scheduling and output demands 0.23* 0.02
Physical demands −0.01 −0.06
Mental and social demands 0.12 0.10
Flexibility demands 0.20 0.08
Work ability as compared to lifetime best 0.05 0.28*
Work difficulties
Physical barriers −0.09 −0.22
Cognitive/psychological barriers −0.21* −0.34*
External barriers −0.11 −0.17
Spearman's correlation coefficients are noted.
⁎ p ≤ 0.002.
Table 4
Cognitive, neuropsychiatric and occupational characteristics of the individuals with MS and healthy controls (HC).







PASAT 3.0 s versiona 49.0 (12.0) 6–60 53.0 (8.0)⁎⁎⁎ 21–60
SDMT correcta 54.0 (11.0) 27–90 60.0 (11.0)⁎⁎⁎ 31–87
RVLT learninga 50.0 (15.0) 23–68 55.5 (13.0)⁎⁎⁎ 29–72
RVLT delayed recalla 10.0 (5.0) 2–15 12.0 (4.0)⁎⁎⁎ 3–15
BVMT-R learninga 28.0 (7.0) 7–36 29.0 (7.0)* 8–36
BVMT-R delayed recalla 11.0 (2.0) 2–12 11.0 (2.0)⁎⁎ 5–12
TMT trails B-Aa 26.0 (17.6) –5–132 24.2 (13.5)* 2–111
DF total correctb 34.6 (6.0) 19–51 35.7 (6.3) 21–53
CWI card 3 + 4 minus card 1 + 2a 52.8 (18.6) –21–173 51.1 (19.1) 19–123
Neuropsychiatric functioning
HADS depressiona 3.0 (5.0) 0–15 1.0 (2.0)⁎⁎⁎ 0–10
HADS anxietya 5.0 (4.0) 0–21 4.0 (2.0)⁎⁎⁎ 0–12
MFISb 37.4 (15.7) 0–80 20.0 (12.7)⁎⁎⁎ 0–66
NEO-FFI neuroticisma 29.0 (11.0) 13–49 26.0 (9.0)⁎⁎⁎ 13–52
NEO-FFI extraversiona 41.0 (10.0) 22–58 44.0 (8.0)⁎⁎⁎ 23–55
NEO-FFI opennessa 36.0 (9.0) 22–56 39.5 (8.0)⁎⁎⁎ 26–54
NEO-FFI agreeablenessa 45.0 (6.0) 31–55 46.0 (7.0) 28–54
NEO-FFI conscientiousnessa 46.0 (7.0) 28–60 47.0 (8.0)⁎⁎ 30–60
Occupational functioning
Presenteeisma 2.0 (3.0) 1–10 1.0 (1.0)⁎⁎⁎ 1–8
Work role functioning
Work scheduling and output demandsa 82.5 (44.0) 0–100 90.0 (36.0) 0–100
Physical demandsa 90.0 (35.0) 0–100 100.0 (53.0)* 0–100
Mental and social demandsa 82.1 (36.0) 0–100 89.3 (45.0) 0–100
Flexibility demandsa 85.0 (35.0) 0–100 90.0 (39.0) 0–100
Work ability as compared to lifetime besta 7.0 (2.0) 0–10 9.0 (1.0)⁎⁎⁎ 0–10
Work difficultiesa
Physical barriers 18.8 (19.0) 0–84 3.1 (9.0)⁎⁎⁎ 0–50
Cognitive/psychological barriers 22.7 (25.0) 0–80 11.4 (16.0)⁎⁎⁎ 0–43
External barriers 25.0 (34.0) 0–100 6.3 (19.0)⁎⁎⁎ 0–94
IQR: Interquartile Range. PASAT: Paced Auditory Serial Addition Test, SDMT: Symbol Digit Modalities Test, RVLT: Rey Verbal Learning Test, BVMT-R: Brief
Visuospatial Memory Test-Revised, TMT: Trail Making Test, DF: Design Fluency Test, CWI: Colour Word Interference Test, HADS: Hospital Anxiety and Depression
Scale, MFIS: Modified Fatigue Impact Scale, NEO-FFI: NEO Five-Factor Personality Inventory. Significant group differences;
⁎ p ≤ 0.05,
⁎⁎ p ≤ 0.01,
⁎⁎⁎ p ≤ 0.001.
a median (IQR).
b mean (SD).
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relationship between social cognition and education is often not found
in samples with younger, less disabled and less progressive individuals
with MS. Chalah et al. (2017) refer to the ‘cognitive reserve hypothesis’
to understand the relationship between social cognition and education,
where a higher educational level is considered one of the protective
factors against cognitive decline, including social cognition, in spite of
MS-related brain damage. This is consistent with the fact that we did
not find a relationship between empathy and educational level in our
healthy control sample.
The identified association between better verbal learning and social
cognition in individuals with MS was observed previously in a study
that used a ToM task, i.e. the Movie for the Assessment of Social
Cognition (Pottgen et al., 2013). It is unclear why we only found a
correlation between empathy and verbal learning, and not with ex-
ecutive functioning (Kraemer et al., 2013; Raimo et al., 2017) or in-
formation processing speed (Pottgen et al., 2013; Chalah et al., 2017) as
was reported in previous studies. Differences may be explained by the
fact that we only used a self-report measure of empathy and did not
include ToM tasks. Using both a ToM task and Baron-Cohen's Empathy
Quotient, Kraemer et al. only established associations between the ToM
task and executive functioning (Kraemer et al., 2013). Consequently,
our positive correlation between self-reported empathy and verbal
learning is a novel one, suggesting an interaction between empathy and
new learning in individuals with MS, possibly reflecting the role of the
hippocampus in both empathy and declarative memory (Beadle et al.,
2013).
While previous studies did not establish associations between social
cognition (mostly ToM) and symptoms of depression (Kraemer et al.,
2013; Pottgen et al., 2013; Chalah et al., 2017; Raimo et al., 2017), the
current study illuminated a negative correlation between empathy and
symptoms of depression in both individuals with MS and healthy con-
trols. A recent study in the general Dutch population reported a similar
negative correlation between cognitive empathy and depression
(Bennik et al., 2019). In contrast, another study reported higher self-
reported dispositional empathy in patients suffering from depression,
mainly driven by increased personal distress (Thoma et al., 2011). As
only 10.1% of the individuals with MS and 1.6% of the healthy controls
in the current sample had depression scores indicative of a clinical
depression (HADS≥ 8), the identified correlation may better be ex-
plained by depressive feelings hindering a person's ability to focus on
others and experience emotions based on their emotions.
In healthy controls, an additional correlation was identified be-
tween higher empathy and a lower impact of fatigue. We did not find
this correlation in individuals with MS, and a previous study also did
not find an association between ToM performance and fatigue in MS
(Chalah et al., 2017). Studies have shown that empathy sometimes
leads to compassion fatigue and sometimes to compassion satisfaction
(Hansen et al., 2018). The healthy controls in our sample seem to ex-
perience more positive feelings (compassion satisfaction) in relation to
their empathy, including less fatigue and less depressive feelings. We
suspect that the type of fatigue experienced by individuals with MS may
be a different type of fatigue (MS-related fatigue) caused by a combi-
nation of MS-related pathophysiological and psychological factors
(Bol et al., 2009), which is unrelated to empathy.
Furthermore, empathy was weakly to moderately correlated with
several personality traits, i.e. higher extraversion, agreeableness and
conscientiousness. The personality trait ‘agreeableness’ was most
strongly correlated with increased empathy, which is not surprising as
persons scoring high on agreeableness are considered kind, empathetic
and cooperative, indicating an overlap in constructs. The observed
correlation between empathy and agreeableness in healthy controls
confirms this hypothesis.
4.3. Relations between empathy and occupational functioning
Empathy did not differ between employed and unemployed
individuals with MS and healthy controls. This may be explained by an
unequal group distribution as most individuals with MS and healthy
controls in the current study were employed (respectively 86.3% and
98.4%). Furthermore, those who were unemployed lost their jobs only
recently.
In individuals with MS, higher empathy was specifically (weakly)
correlated with better occupational functioning in terms of being able
to finish work in time, with an acceptable speed and without errors
(WRFQ-2.0- work scheduling and output demands). This relationship
seems consistent with the previously reported relationship between
empathy and executive abilities at work (Kraemer et al., 2013;
Raimo et al., 2017). In both individuals with MS and healthy controls,
higher empathy was weakly to moderately associated with experiencing
less cognitive and psychological barriers at work (MSWDQ-23) in-
cluding less difficulties in communicating with colleagues, interacting
with other people and planning. This relationship seems to reflect the
link between empathy and communicating and interacting with others.
In healthy controls, higher empathy was also weakly correlated with
better work ability as compared to lifetime best, which is a more gen-
eral measure of work ability.
There is a general lack of evidence in previous studies supporting
these specific findings, as most investigations seem to focus on the re-
lationship between empathy and burnout in healthcare professionals or
medical students. However, such investigations do indicate that higher
empathy in healthcare professionals is associated with less emotional
exhaustion and depersonalization, and higher personal accomplish-
ment, confirming a link between empathy and better occupational
functioning (Williams et al., 2017).
4.4. Strengths and limitations
Strengths of the current study include the large sample of 287 in-
dividuals with MS and 128 healthy controls. We included a detailed
examination of neuropsychological and neurological functioning.
Furthermore, within the MS@Work study we had the opportunity to
examine relations between empathy and occupational functioning in
individuals with MS, which has not been previously done. A limitation
is that our findings are not representative of the entire MS population,
as the MS@Work study specifically recruited individuals with relap-
sing-remitting MS with a current or recent paid job, who coincidentally
had mild disability (Median EDSS of 2.0). A final limitation is that we
only included a self-report measure of empathy, i.e. Baron-Cohen's
Empathy Quotient. It would be very interesting to further examine the
relationship between ToM tasks and cognitive, psychological and oc-
cupational functioning, and to also include individuals with more se-
vere MS symptoms.
5. Conclusions
The current study revealed no differences in empathy between in-
dividuals with MS and healthy controls. Higher empathy was weakly to
moderately correlated with less symptoms of depression, higher
agreeableness and better occupational functioning in both individuals
with MS and healthy controls.
In individuals with MS, higher empathy was additionally correlated
with a higher educational level, better verbal learning, higher extra-
version, higher conscientiousness and better occupational functioning
in terms of work scheduling and output demands. These might be MS-
specific correlations that become apparent with increased brain damage
and associated decreases in cognitive functioning, increased use of
cognitive reserve capacities and changes in personality.
In healthy controls, higher empathy was additionally correlated
with less fatigue and better work ability as compared to lifetime best.
These may represent more general correlations between constructs re-
presenting aspects of well-being that disappear in individuals with MS.
It remains unclear in this observational, cross-sectional study whether
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the observed correlations reflect empathy as a cause or an effect of
better cognitive, psychological and occupational functioning, or whe-
ther brain functioning (either healthy or pathological) is the common
denominator affecting all aforementioned factors.
Future studies ought to consider examining changes in social cog-
nition longitudinally in both healthy controls and individuals with MS
of differing disease severity and see whether these changes precede,
follow or co-occur with changes in cognitive, psychological and occu-
pational functioning. It would be particularly interesting to con-
currently examine changes in the brain network involved with social
cognition.
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